Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy
{{output}}
Oligonucleotide-based therapeutics offer precise genetic and immunological modulation but meet critical barriers including instability, poor cellular uptake, and carrier-associated toxicity. Although spherical nucleic acids (SNAs) provide a robust framework, t... ...
